Epilepsy Trial, Recruiting (NCT05981755)

Epilepsy Trial, Recruiting NCT05981755 Sponsor: The University of Texas Health Science Center, Houston Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT05981755 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with focal epilepsy that has not been controlled by treatment
People who have been admitted to the Epilepsy Monitoring Unit at Memorial Hermann-Texas Medical Center for an invasive brain monitoring procedure using electrodes placed on or in the brain

Who may not be able to join:

People who have a respiratory (breathing), heart, or blood vessel/stroke-related disease
People who are pregnant
People who are currently imprisoned

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nuria L Lecumberri, MD,PhD, The University of Texas Health Science Center, Houston

Phone: 713-500-7785

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05981755

Sponsor: The University of Texas Health Science Center, Houston

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: 713-500-7785

More information: https://clinicaltrials.gov/study/NCT05981755

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with focal epilepsy that has not been controlled by treatment
People who have been admitted to the Epilepsy Monitoring Unit at Memorial Hermann-Texas Medical Center for an invasive brain monitoring procedure using electrodes placed on or in the brain

Who may not be able to join:

People who have a respiratory (breathing), heart, or blood vessel/stroke-related disease
People who are pregnant
People who are currently imprisoned

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The University of Texas Health Science Center, Houston

Registry

ClinicalTrials.gov

Start date

31 July 2023

Est. completion

30 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in percentage of breathing node size as assessed by electroencephalogram (EEG) signal; Change in presence of breathing nodes as assessed by EEG signal; Changes in thoracoabdominal circumference during stimulation as assessed by thoracoabdominal belts,; Changes airflow during stimulation as assessed by the nasal/oral pressure transducer [BiNAPS]; Change in Saturation of peripheral oxygen (SpO2) during stimulation as assessed by the pulse oximetry; Change in end tidal carbon dioxide (CO2) during stimulation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov